Discusses that loss of NME RNA or protein expression has been associated with the development of metastatic disease and/or reduced patient survival in breast cohort studies. Transfection of nm-23-H1 complementary DNA into the metastatic human breast carcinoma cell line; Reduction of colonization and motility in vitro; Targets of LOH-associated mutations; More.